ArchiMed’s $1.2bn private equity deal with Natus Medical was the Medical devices industry’s biggest deal of Q2 2022 as deals worth $12.2bn were announced globally in the quarter, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 32% over the previous quarter and a drop of 69.3% when compared with the last four-quarter average of $39.55bn.

In terms of number of deals, the sector saw a drop of 11.49% with 539 deals in Q2 2022 against the average of 609.00 deals in the last four-quarters.

In value terms, North America led the activity with deals worth $5.39bn.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Medical devices industry deals in Q2 2022: Top deals

The top five Medical devices industry deals accounted for 33.5% of the overall value during Q2 2022.

The combined value of the top five deals stood at $4.07bn, against the overall value of $12.2bn recorded for the quarter.

The top five Medical devices industry deals of Q2 2022 tracked by GlobalData were:

1) ArchiMed $1.2bn private equity deal with Natus Medical

2) The $1bn acquisition of MediFox DAN Group by ResMed

3) EQT IX Fund $797.86m private equity deal with SPT Labtech

4) The $541.63m acquisition of Phenox by Wallaby Medical

5) Fleury $534.27m acquisition deal with Instituto Hermes Pardini